B. Reymen

发表

Longitudinal radiomics of cone-beam CT images from non-small cell lung cancer patients: Evaluation of the added prognostic value for overall survival and locoregional recurrence

Yolande Lievens, Carsten Brink, Philippe Lambin, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Survival prediction of non-small cell lung cancer patients using radiomics analyses of cone-beam CT images.

Carsten Brink, Philippe Lambin, Wouter van Elmpt, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Decision support systems for personalized and participative radiation oncology☆

P. Lambin, R. Larue, M. V. van Gisbergen, 2017, Advanced drug delivery reviews.

Automatic selection of lung cancer patients for adaptive radiotherapy using cone-beam CT imaging

W. V. Elmpt, M. Öllers, B. Reymen, 2017 .

Learning methods in radiation oncology ‘Rapid Learning health care in oncology’ – An approach towards decision support systems enabling customised radiotherapy’ q

P. Lambin, R. Leijenaar, E. R. Velazquez, 2013 .

A prospective study comparing the predictions of doctors versus models for treatment outcome of lung cancer patients: a step toward individualized care and shared decision making.

P. Lambin, E. Steyerberg, A. Dekker, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prognostic value of metabolic metrics extracted from baseline positron emission tomography images in non-small cell lung cancer

Andre Dekker, Esther G C Troost, Robert Gillies, 2013, Acta oncologica.

Radiomics Digital Phantom

P. Lambin, R. Leijenaar, J. Bussink, 2016 .

Modern clinical research: How rapid learning health care and cohort multiple randomised clinical trials complement traditional evidence based medicine

Frank Verhaegen, Frank Hoebers, Andre Dekker, 2015, Acta oncologica.

Shared decision-making for prophylactic cranial irradiation in extensive-stage small-cell lung cancer: an exploratory study

A. Dekker, D. de Ruysscher, B. Reymen, 2021, Translational lung cancer research.

State of the art radiation therapy for lung cancer 2012: a glimpse of the future.

Frank Hoebers, Philippe Lambin, Wouter van Elmpt, 2013, Clinical lung cancer.

Standard of care in high-dose radiotherapy for localized non-small cell lung cancer

W. V. van Elmpt, D. de Ruysscher, S. Peeters, 2017, Acta oncologica.

Current status of immune checkpoint inhibition in early stage NSCLC.

D. de Ruysscher, D. Ruysscher, S. Peters, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial).

J. Sonke, W. V. van Elmpt, D. de Ruysscher, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Predicting tumor hypoxia in non-small cell lung cancer by combining CT, FDG PET and dynamic contrast-enhanced CT

Felix M Mottaghy, Marco Das, Philippe Lambin, 2017, Acta oncologica.

Total gross tumor volume is an independent prognostic factor in patients treated with selective nodal irradiation for stage I to III small cell lung cancer.

P. Lambin, D. de Ruysscher, A. Dingemans, 2013, International journal of radiation oncology, biology, physics.

Immunotherapy in unresectable stage III non-small cell lung cancer: state of the art and novel therapeutic approaches.

D. de Ruysscher, J. Vansteenkiste, B. Reymen, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

Radiotherapy in early stage Hodgkin's lymphoma: The importance of volume and treatment position.

B. Reymen, Y. Lievens, S. Spiessens, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Clustering of multi-parametric functional imaging to identify high-risk subvolumes in non-small cell lung cancer.

P. Lambin, F. Mottaghy, W. V. van Elmpt, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Feature selection methodology for longitudinal cone-beam CT radiomics

Philippe Lambin, Wouter van Elmpt, Bart Reymen, 2017, Acta oncologica.

Clinician perspectives on clinical decision support systems in lung cancer: Implications for shared decision‐making

D. de Ruysscher, C. Oberije, A. Dekker, 2022, Health expectations : an international journal of public participation in health care and health policy.

Non-small cell lung cancer, locally advanced

P. Lambin, S. Kozlov, I. Petersen, 2012 .

High-dose hyperfractionated accelerated radiotherapy in non-small cell lung cancer.

D. de Ruysscher, A. V. van Baardwijk, B. Reymen, 2011, Minerva chirurgica.

Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer: 5-Year results of a prospective study.

D. de Ruysscher, G. Bootsma, C. Pitz, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Characterization of tumour heterogeneity using dynamic contrast enhanced CT and FDG-PET in non-small cell lung cancer

P. Lambin, W. V. Elmpt, D. Ruysscher, 2015 .

Progression‐Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450)

D. de Ruysscher, G. Bootsma, C. Pitz, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Radiation-induced oesophagitis in lung cancer patients

P. Lambin, D. Ruysscher, C. Oberije, 2012, Strahlentherapie und Onkologie.

Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial.

E. Smit, C. Faivre-Finn, S. Senan, 2017, Lung cancer.

Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial

P. Lambin, P. Wesseling, D. de Ruysscher, 2020, Autophagy.

No association between TGF-β1 polymorphisms and radiation-induced lung toxicity in a European cohort of lung cancer patients.

P. Lambin, H. Thierens, A. Voets, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Targeting Hypoxia to Improve Non–Small Cell Lung Cancer Outcome

P. Lambin, C. Faivre-Finn, C. West, 2018, Journal of the National Cancer Institute.

Radical Treatment of Non–Small-Cell Lung Cancer Patients with Synchronous Oligometastases: Long-Term Results of a Prospective Phase II Trial (Nct01282450)

P. Lambin, D. de Ruysscher, G. Bootsma, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Nitroglycerin as a radiosensitizer in non-small cell lung cancer: Results of a prospective imaging-based phase II trial

P. Lambin, M. V. van Gisbergen, L. Dubois, 2019, Clinical and translational radiation oncology.

18F-FDG-PET guided vs whole tumour radiotherapy dose escalation in patients with locally advanced non-small cell lung cancer (PET-Boost): results from a randomised clinical trial.

J. Sonke, W. V. van Elmpt, K. Sikorska, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A secondary analysis of FDG spatio-temporal consistency in the randomized phase II PET-boost trial in stage II-III NSCLC.

J. Sonke, W. V. van Elmpt, D. de Ruysscher, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Is selective nodal irradiation in non-small cell lung cancer still safe when using IMRT? Results of a prospective cohort study.

P. Lambin, D. de Ruysscher, A. V. van Baardwijk, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

PET-based dose painting in non-small cell lung cancer: Comparing uniform dose escalation with boosting hypoxic and metabolically active sub-volumes.

Philippe Lambin, Wouter van Elmpt, Judith van der Stoep, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Is high-dose stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC) overkill? A systematic review.

Philippe Lambin, Wouter van Elmpt, Dirk De Ruysscher, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Mature results of a phase II trial on individualised accelerated radiotherapy based on normal tissue constraints in concurrent chemo-radiation for stage III non-small cell lung cancer.

P. Lambin, D. de Ruysscher, G. Bootsma, 2012, European journal of cancer.

Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: a prospective population-based study.

Andre Dekker, Philippe Lambin, Geert Bosmans, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Treatment with curative intent of stage III non-small cell lung cancer patients of 75 years: a prospective population-based study.

P. Lambin, D. de Ruysscher, G. Bootsma, 2011, European journal of cancer.

In Vivo Quantification of Hypoxic and Metabolic Status of NSCLC Tumors Using [18F]HX4 and [18F]FDG-PET/CT Imaging

P. Lambin, F. Mottaghy, F. Hoebers, 2014, Clinical Cancer Research.

Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion

P. Lambin, F. Mottaghy, W. V. van Elmpt, 2015, European Journal of Nuclear Medicine and Molecular Imaging.

Tumor regression during radiotherapy for non-small cell lung cancer patients using cone-beam computed tomography images

J. E. van Timmeren, W. V. van Elmpt, D. de Ruysscher, 2019, Strahlentherapie und Onkologie.

University of Southern Denmark Tumor regression during radiotherapy for non-small cell lung cancer patients using cone- beam computed tomography images

J. V. Timmeren, W. V. Elmpt, D. Ruysscher, 2019 .

Longitudinal radiomics of cone-beam CT images from non-small cell lung cancer patients: Evaluation of the added prognostic value for overall survival and locoregional recurrence

J. E. van Timmeren, P. Lambin, R. Leijenaar, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Applicability of a prognostic CT-based radiomic signature model trained on stage I-III non-small cell lung cancer in stage IV non-small cell lung cancer.

Esther G.C. Troost, Philippe Lambin, Wouter van Elmpt, 2018, Lung cancer.

A Phase I Study of Concurrent Individualized, Isotoxic Accelerated Radiotherapy and Cisplatin–Vinorelbine–Cetuximab in Patients With Stage III Non–Small-Cell Lung Cancer

P. Lambin, D. de Ruysscher, A. Dingemans, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Determinants of Sequential versus Concurrent Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer Patients

J. Bussink, J. Belderbos, J. Widder, 2015 .

Comparative evaluation of autocontouring in clinical practice: A practical method using the Turing test

Paul Aljabar, Andre Dekker, Devis Peressutti, 2018, Medical physics.

Electronic Health Record implementation in a large academic radiotherapy department: Temporarily disruptions but long-term benefits

Andre Dekker, Godefridus G. van Merode, Bart Reymen, 2019, Int. J. Medical Informatics.

Hypoxia imaging with [¹⁸F]HX4 PET in NSCLC patients: defining optimal imaging parameters.

P. Lambin, F. Mottaghy, F. Hoebers, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiation-Induced Lung Density Changes on CT Scan for NSCLC: No Impact of Dose-Escalation Level or Volume.

J. Sonke, D. de Ruysscher, J. Belderbos, 2018, International journal of radiation oncology, biology, physics.

Personalized Medicine and Imaging In Vivo Quanti fi cation of Hypoxic and Metabolic Status of NSCLC Tumors Using [ 18 F ] HX 4 and [ 18 F ] FDG-PET / CT Imaging

P. Lambin, F. Mottaghy, F. Hoebers, 2014 .

Long-term survival of stage T4N0-1 and single station IIIA-N2 NSCLC patients treated with definitive chemo-radiotherapy using individualised isotoxic accelerated radiotherapy (INDAR).

P. Lambin, D. de Ruysscher, A. Dingemans, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The Dutch Lung Cancer Audit-Radiotherapy (DLCA-R): Real-World Data on Stage III Non-Small Cell Lung Cancer Patients Treated With Curative Chemoradiation.

E. Dieleman, N. C. van der Voort van Zyp, J. Pomp, 2022, Clinical lung cancer.

Characterization of tumor heterogeneity using dynamic contrast enhanced CT and FDG-PET in non-small cell lung cancer.

W van Elmpt, D De Ruysscher, P Lambin, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

'Rapid Learning health care in oncology' - an approach towards decision support systems enabling customised radiotherapy'.

P. Lambin, R. Leijenaar, E. R. Velazquez, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial.

E. Smit, C. Faivre-Finn, S. Senan, 2017, Lung cancer.

Applicability of a prognostic CT-based radiomic signature model trained on stage I-III non-small cell lung cancer in stage IV non-small cell lung cancer.

P. Lambin, R. Leijenaar, A. Jochems, 2018, Lung cancer.